Drug Target Validation
Prioritize and identify genetic variants as potential drug targets using our VERG platform.
Ranomics' streamlined enables the characterization of thousands of genetic variants at once using a diverse set of biological readouts including:
Our analyses can be conducted across multiple cell lines to assess whether any genetic variant contributes to disease etiology and can serve as an effective therapeutic target.
Accelerate cell-based studies with Ranomics and identify high-quality drug targets faster.